Pending AI
The AI engine Fit Assessment
BetaPending.AI effectively utilizes machine learning to enhance drug discovery, pattern discovery, and the development of new therapeutics.
Blurb
Artificial intelligence- and quantum mechanics-based capabilities to Design, Make, Test, and Analyse novel pharmaceuticals.
HQ Location
Australia
Founded
2018
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Venture - Series Unknown, January 1, 2021
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Developer of comprehensive discovery platform enabled by artificial intelligence and quantum mechanics, ushering in a new paradigm of medicinal innovation where higher-quality small molecule drugs can be developed in a fraction of the time and cost. The company's operation are presences across both Boston, Massachusetts, United States and Eveleigh, New South Wales, Australia, enabling scientists in the pharmaceutical industry to design, make, and test new drugs to treat diseases.